ESC 365 - Warfarin and aspirin versus warfarin alone in patients with HeartMate 3 left ventricular assist device: a systematic review and meta-analysis.

HFA Premium Access

Warfarin and aspirin versus warfarin alone in patients with HeartMate 3 left ventricular assist device: a systematic review and meta-analysis.

Session: Chronic heart failure - treatment 6

Topic: Ventricular Assist Devices

Speaker: Mr L. Rezende De Freitas (BR)

Event: Heart Failure 2024

Congress Presentation

About the speaker

Mr Lucas Rezende De Freitas

(Brazil)

0 follower

6 more presentations in this session

Histological profiling, viral analysis, and follow-up of inflammatory cardiomyopathy in adults supported by long-term left ventricular assist device therapy

Speaker: Doctor M. Ruiz Cano (Bad Oeynhausen, DE)

The impact of sodium glucose transporter 2 inhibitors on cardiac remodeling in a large cohort of unselected patients

Speaker: Doctor V. Copeland (Ramat Gan, IL)

Impact of hemodynamic optimization on reducing pulmonary pressures and adverse clinical events in left ventricular assist device recipients with elevated pulmonary vascular resistance

Speaker: Professor M. Kim (Seoul, KR)

Impact of an extended infectiological standard operating procedure on the outcome of patients with VAD-associated infections

Speaker: Mr Y. Streef (Berlin, DE)

Clinical and echocardiographic effects of vericiguat therapy in advanced heart failure patinets undergoing LVAD support

Speaker: Associate Professor G. Poglajen (Ljubljana, SI)

Access the full session

Chronic heart failure - treatment 6

Speakers: Mr L. Rezende De Freitas, Doctor M. Ruiz Cano, Doctor V. Copeland, Professor M. Kim, Mr Y. Streef...

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources